Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) Files Technology Patent Application Covering Bioavailability-Enhancing, Nanoemulsion-Empowered Formulations
Nov 15, 2021
- Mydecine has filed a technology patent application that allows for the creation of nanoemulsion-empowered formulations to improve, stabilize, and increase the bioavailability of ingredients
- The company aims to use the nanoemulsion technology to enhance the bioavailability and optimize the delivery of compounds that are inspired by traditional ingredients
- In September, Mydecine filed its final patent application for MYCO-003, one of its lead drug candidates for enhanced treatment of anxiety and post-traumatic stress disorder
- MYCOF is steadily strengthening its IP portfolio as it seeks to reimagine the treatment of mental health and addiction
Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF), an emerging biotechnology and digital company dedicated to efficiently developing first- and second-generation novel therapeutics to treat PTSD, addiction, and other mental health disorders, has achieved a significant milestone for its drug development pipeline.
The Denver-based company recently filed a technology patent application that will cover as well as allow for the creation of formulations that use nanoemulsion technology to improve, stabilize, increase bioavailability, and make repeatable properties of ingredients from…
NOTE TO INVESTORS: The latest news and updates relating to MYCOF are available in the company’s newsroom at https://ibn.fm/MYCOF
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]
BioMedWire is part of the InvestorBrandNetwork.
More News
Taiwan to close Papua New Guinea office and halt spot-market LNG purchases
Taiwan will close its representative office in Papua New Guinea later this month after the Pacific island country repeatedly demanded its closure, citing its “one-China policy”. The withdrawal will cut off Taiwanese technical assistance and end decades of cooperation with PNG, including halting spot-market purchases of the country’s liquefied natural gas (LNG) – a move Taipei said could deal a blow to the nation’s export earnings. “It is deeply regrettable that, under pressure from [Beijing],...
In 2024, 1,865 volunteers reviewed underwater videos; cameras recorded 4 fish species missed by traditional traps
The Where's Walleye? project showcases how researchers leveraged traditional fish traps and high-tech underwater cameras to refine fish survey methods. With assistance from 1,865 citizen scientists, the project analyzed video footage to identify diverse fish species. Remarkably, the underwater cameras uncovered four species previously missed by conventional techniques, enhancing our comprehension of aquatic ecosystems and aiding in rare species monitoring.
Possession delayed? Your rights as a homebuye
88% of Nvidia Staff backed Jensen Huang as CEO. Then came a second affair report: Who decides if he stays?
A Blind poll found that 88% of the 232 Nvidia employees surveyed wanted Jensen Huang to stay as CEO. Nvidia opened an independent inquiry into whether Huang was targeted by a foreign intelligence effort. Reuters reported that directors met Wednesday to consider his future. Nvidia had yet to announce a decision as of Nov. 12.
IIT Kharagpur becomes first IIT to offer NMC-accredited postgraduate medical degrees
IIT Kharagpur is set to become the first IIT to offer postgraduate medical degree programmes. The inaugural cohort of MD students will begin in the academic session 2026-27 at the Dr B C Roy Multi-Speciality Medical Research Centre. Admissions will be conducted through the NEET-PG online counselling process for qualified candidates. Six MD disciplines will be offered, each with two available seats.
IIT Kharagpur becomes first IIT to offer NMC-accredited postgraduate medical degrees
IIT Kharagpur is set to become the first IIT to offer postgraduate medical degree programmes. The inaugural cohort of MD students will begin in the academic session 2026-27 at the Dr B C Roy Multi-Speciality Medical Research Centre. Admissions will be conducted through the NEET-PG online counselling process for qualified candidates. Six MD disciplines will be offered, each with two available seats.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.